Side by side
Compare compounds
Add up to three compounds with the compare button on any library card or compound page.
Swipe the table sideways to see every compound.
| Attribute |  |
|---|---|
| Category | Hormonal |
| Evidence grade | A Human trial evidence |
| Regulatory status | FDA-approved |
| Human amounts | FDA labelDosing reference Study durations |
| Format | |
| Type | Single compound |
| Molecular formula | C49H66N10O10S2 |
| Molecular weight | 1,019.2 g/mol |
| CAS number | 83150-76-9 |
| Sequence | D- |
| References | 7 |
| Summary | Octreotide is a synthetic eight-residue somatostatin analog, FDA-approved since 1988 (Sandostatin, Sandostatin LAR Depot, and oral Mycapssa) for acromegaly and for diarrhea and flushing from carcinoid tumors and VIPomas. |